Aprogen KIC's Domestic Patent on Antibodies for Breast Cancer Treatment
[Asia Economy Reporter Oh Ju-yeon] Aprogen KIC announced on the 29th that it has obtained a domestic patent related to an antibody for breast cancer treatment. The company stated, "We plan to produce clinical samples at the factory of our affiliate Aprogen Biologics and aim to start global clinical trials as soon as possible to develop it as a new drug."
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
